Enzymes Controlling the Biosynthesis of Catecholamines

  • M. Goldstein
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 2)


Isotopic studies have confirmed the proposed major pathway for the biogenesis of norepinephrine and epinephrine [1]. The main steps in this pathway are the oxidation of phenylalanine to tyrosine followed by hydroxylation to 3,4-dihydroxyphenylalanine, decarboxylation to dopamine, β-hydroxylation of dopamine to norepinephrine and N-methylation of norepinephrine to epinephrine. In addition, some other minor pathways were postulated (Fig. 1). Although evidence for the main pathway was well established a decade ago, only recently, all the enzymes which control the biosynthesis of catecholamines were isolated and their properties characterized. Based on these studies it is now possible to investigate the activities of these enzymes in tumors such as neuroblastoma and pheochromocytoma, and to determine which of those enzymes is responsible for the overproduction of catecholamines.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Blaschko, H.: In M. Harington (Editor): Hypotensive drugs. London: Pergamon Press 956, p. 23.Google Scholar
  2. [2]
    Kaufman, S.: J. Biol. Chem. 234, 2677 (1959).PubMedGoogle Scholar
  3. [3]
    Nagatsu, R., M. Levitt, and S. Udenfriend: Biodiem. Biophys. Res. Commun. 14, 543 (1964).CrossRefGoogle Scholar
  4. [4]
    Nagatsu, R., M. Levitt, and S. Udenfriend: J. Biol. Chem. 239, 2910 (1964).PubMedGoogle Scholar
  5. [5]
    Lovenberg, W., H. Weissbach, and S. Udenfriend: J. Biol. Chem. 237, 89 (1962).PubMedGoogle Scholar
  6. [6]
    Oates, J. A., L. Gillespie, S. Udenfriend, and A. Sjoerdsma: Science (Washington) 131, 1890 (1960).CrossRefGoogle Scholar
  7. [7]
    Porter, C. C., L. S. Watson, D. C. Titus, J. A. Totaro, and S. S. Byer: Biochem. Pharmacol. 11, 1067 (1962).PubMedCrossRefGoogle Scholar
  8. [8]
    Levin, E. Y., B. Levenberg, and S. Kaufman: J. Biol. Chem. 235, 2080 (1960).PubMedGoogle Scholar
  9. [9]
    Goldstein, M.: To be published.Google Scholar
  10. [10]
    Levin, E. Y., and S. Kaufman: J. Biol. Chem. 236, 2043 (1961).PubMedGoogle Scholar
  11. [11]
    Goldstein, M., and J. F. Contrera: J. Biol. Chem. 237, 1898 (1962).PubMedGoogle Scholar
  12. [12]
    Creveling, C. R.: Ph. D. Thesis, Georgetown University, Washington D.C. 1962.Google Scholar
  13. [13]
    Goldstein, M., M. R. Kereghan, and E. Lauber: Biochim. biophys. Acta 89, 191 (1964).PubMedGoogle Scholar
  14. [14]
    Creveling, C. R., M. Levitt, and S. Udenfriend: Life Sci. 1, 523 (1962).PubMedCrossRefGoogle Scholar
  15. [15]
    Lemberger, L.: Fed. Proc. 23, 2758 (1964).Google Scholar
  16. [16]
    Musacchio, J. M., and M. Goldstein: Biochem. Pharmacol. 12, 1061 (1963).PubMedCrossRefGoogle Scholar
  17. [17]
    Goldstein, M., and J. M. Musacchio: Biochem. Pharmacol. 11, 809 (1962).PubMedCrossRefGoogle Scholar
  18. [18]
    Creveling, C. R., J. B. VAN DER Schoot, and S. Udenfriend: Biochem. Biophys. Res. Commun. 8, 215 (1962).PubMedCrossRefGoogle Scholar
  19. [19]
    Goldstein, M., E. Lauber, and M. R. Mckereghan: Biochem. Pharmacol. 13, 1103 (1964).PubMedCrossRefGoogle Scholar
  20. [20]
    Green, A. L.: Biochim. biophys. Acta 81, 394 (1964).Google Scholar
  21. [21]
    Goldstein, M.: Life Sci. 3, 763 (1964).PubMedCrossRefGoogle Scholar
  22. [22]
    Musacchio, J. M.: Life Sci. 3, 769 (1964).PubMedCrossRefGoogle Scholar
  23. [23]
    Goldstein, M.: TO be published.Google Scholar
  24. [24]
    Kirshner, N.: Biochim. biophys. Acta 24, 658 (1957).PubMedCrossRefGoogle Scholar
  25. [25]
    Cantoni, G.: Phosphorus Metabolism, vol. I p. 641. Ed. by W. D. McElroy and B. Glass. Baltimore: Johns Hopkins Press 1951.Google Scholar
  26. [26]
    Axelrod, J.: J. Biol. Chem. 237, 1657 (1962).PubMedGoogle Scholar
  27. [27]
    Axelrod, J.: J. Pharmacol. exp. Ther. 138, 28 (1962).PubMedGoogle Scholar
  28. [28]
    Armstrong, M. D., A. Mcmillan, and K. N. F. Shaw: Biochim. biophys. Acta 25, 422 (1957).PubMedCrossRefGoogle Scholar
  29. [29]
    Kelly, H. M.: Proc. Staff Meet. Mayo Clin. 11, 65 (1936).Google Scholar
  30. [30]
    Goldenberg, M.: Amer. J. Med. 10, 627 (1951).PubMedCrossRefGoogle Scholar
  31. [31]
    Voorhess, M. L., and L. I. Gardner: J. clin. Endocr. 21, 321 (1961).PubMedCrossRefGoogle Scholar
  32. [32]
    Studnitz, W. VON: Lancet 1961, 215.Google Scholar
  33. [33]
    Studnitz, W. VON: This meeting.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1966

Authors and Affiliations

  • M. Goldstein
    • 1
  1. 1.Neurochemistry Laboratories, Department of Psychiatry and NeurologyNew York University Medical CenterNew York 16USA

Personalised recommendations